Dihydrotestosterone, commonly called DHT, is the primary hormone responsible for hair loss in women. DHT shrinks hair follicles over time, producing progressively thinner and shorter strands until some follicles stop producing visible hair altogether. But DHT rarely acts alone. Hair loss in women typically results from a shifting balance among several hormones, including estrogen, cortisol, and insulin, each of which can amplify or counteract DHT’s effects.
How DHT Shrinks Hair Follicles
Your body produces DHT when an enzyme called 5-alpha reductase converts testosterone into its more potent form. Every woman has some testosterone circulating in her blood, and that means every woman produces some DHT. The problem isn’t DHT itself but how genetically susceptible your hair follicles are to it.
In follicles that are sensitive to DHT, the hormone shortens the growth phase of the hair cycle. A healthy hair follicle can stay in its active growth phase for two to six years, producing a long, thick strand. When DHT interferes, that window shrinks. The follicle produces a finer, shorter hair with each cycle. Over time, this process of “miniaturization” turns thick terminal hairs into barely visible ones, and eventually the follicle may go dormant entirely. This is the core mechanism behind female pattern hair loss, the most common type of hair thinning in women.
Why Estrogen Matters So Much
Estrogen acts as a natural counterweight to DHT. It prolongs the growth phase of hair follicles, increases the number of actively growing follicles, and improves blood flow to the scalp so follicles get the nutrients they need. Estrogen also helps maintain a balance between itself and testosterone, reducing how much testosterone gets converted into DHT in the first place.
This is why hair loss in women so often tracks with estrogen levels. When estrogen is high, as it is during pregnancy, many women notice their hair is thicker and fuller than usual. When estrogen drops, the balance tips in favor of androgens like DHT, and hair begins to thin. The hormone itself doesn’t vanish overnight, but the protective buffer it provides weakens significantly during certain life stages.
Menopause and Postpartum Hair Loss
Menopause is the most common trigger for hormonally driven hair loss in women. As estrogen and progesterone decline, DHT gains more influence over susceptible follicles. The growth cycle shortens, follicles shrink, and hair gradually thins across the top of the scalp. A cross-sectional study of 178 postmenopausal women published by the North American Menopause Society found that 52.2% had female pattern hair loss. In other words, more than half of women will experience noticeable thinning after menopause.
Postpartum hair loss works differently. During pregnancy, elevated estrogen keeps a larger-than-normal number of hairs locked in their growth phase. After delivery, estrogen drops sharply, and all those hairs that were “held back” enter the shedding phase at once. This type of shedding, called telogen effluvium, can be dramatic, with clumps coming out in the shower or on your pillow. It typically peaks around three to four months after giving birth and resolves on its own within six to twelve months as hormone levels stabilize.
Cortisol and Stress-Related Shedding
Cortisol, the body’s main stress hormone, contributes to hair loss through a different pathway. When you’re under chronic stress, whether physical or emotional, cortisol levels stay elevated for prolonged periods. High cortisol degrades key structural substances in the skin surrounding hair follicles, including proteoglycans and hyaluronic acid, both of which help maintain the environment follicles need to cycle normally.
This disruption can push large numbers of follicles out of the growth phase prematurely, triggering telogen effluvium. It can also worsen existing androgenetic (pattern) hair loss and contribute to alopecia areata, an autoimmune condition where the immune system attacks hair follicles directly. Stress-related shedding often appears two to three months after the stressful event, which makes it difficult to connect cause and effect without looking back at what happened in the preceding months.
PCOS, Insulin, and Androgen Excess
Polycystic ovary syndrome is one of the most common hormonal conditions in women of reproductive age, and hair thinning is a frequent symptom. PCOS often involves elevated levels of androgens like testosterone and DHEAS, which feed the production of DHT. But the relationship between PCOS and hair loss is more complicated than simple androgen overload. Research published in Fertility and Sterility found that hair loss in PCOS patients didn’t clearly correlate with measurable androgen levels in blood tests, suggesting that follicle sensitivity to androgens matters as much as how much androgen is circulating.
Insulin resistance, which affects many women with PCOS, adds another layer. When insulin levels are chronically high, the liver produces less of a protein called sex hormone-binding globulin (SHBG). SHBG normally binds to testosterone in the bloodstream, keeping it inactive. With less SHBG available, more testosterone circulates freely and more of it gets converted into DHT. Studies have found a significant negative correlation between insulin resistance and SHBG levels in patients with pattern hair loss, and those patients had higher free testosterone than controls. This means that managing insulin resistance, through diet, exercise, or medication, can indirectly reduce the hormonal pressure on hair follicles.
Prolactin and Thyroid Hormones
Elevated prolactin, a condition called hyperprolactinemia, is a less common but recognized cause of hair changes in women. Prolactin is the hormone responsible for milk production, but when levels stay abnormally high outside of pregnancy (often due to a benign pituitary growth called a prolactinoma), it can disrupt estrogen production and contribute to androgen-related symptoms including hair thinning, acne, and excess facial or body hair.
Thyroid hormones also play a role, though they work differently from androgens. Both an underactive thyroid (hypothyroidism) and an overactive thyroid (hyperthyroidism) can cause diffuse hair shedding because thyroid hormones regulate the metabolic activity of virtually every cell, including hair follicle cells. Thyroid-related hair loss tends to affect the entire scalp rather than thinning at the part line or crown, and it typically reverses once thyroid levels are brought back to normal.
How Hormonal Hair Loss Is Treated
Because DHT is the central driver of female pattern hair loss, treatments often focus on reducing its production or blocking its effects at the follicle. Spironolactone is one of the most commonly prescribed options for women. Originally developed as a blood pressure medication, it also blocks androgen receptors, preventing DHT from acting on hair follicles. A study in the Journal of the American Academy of Dermatology found that all female patients treated with spironolactone at an average dose of 100 mg daily either maintained their hair density or improved it, with more significant gains in women who started treatment at more advanced stages of thinning. Results were assessed at six-month intervals, and many patients continued treatment for a year or longer.
Topical minoxidil, available over the counter, works independently of hormones by stimulating blood flow to follicles and extending the growth phase. It’s often used alongside hormonal treatments for a combined effect. For women whose hair loss is linked to a specific hormonal imbalance, such as PCOS, thyroid dysfunction, or hyperprolactinemia, treating the underlying condition can slow or reverse the shedding.
The timeline for visible improvement is slow regardless of the approach. Hair follicles cycle over months, not weeks, so most women need at least six months of consistent treatment before they can judge whether it’s working. Starting earlier, when thinning is mild, gives treatments more to work with since miniaturized follicles that haven’t yet gone dormant respond better than those that have been inactive for years.